Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective

Background In phenylketonuria (PKU), modified casein glycomacropeptide supplements (CGMP-AA) are used as an alternative to the traditional phenylalanine (Phe)-free L-amino acid supplements (L-AA). However, studies focusing on the long-term nutritional status of CGMP-AA are lacking. This retrospectiv...

Full description

Bibliographic Details
Main Author: Pena, MJ (author)
Other Authors: Pinto, A (author), de Almeida, MF (author), Barbosa, CD (author), Ramos, PC (author), Rocha, S (author), Guimas, A (author), Ribeiro, R (author), Martins, E (author), Bandeira, A (author), Dias, CC (author), MacDonald, A (author), Borges, Nuno (author), Rocha, JC (author)
Format: article
Language:eng
Published: 2021
Subjects:
Ciências da Saúde, Ciências médicas e da saúde
Health sciences, Medical and Health sciences
Online Access:https://hdl.handle.net/10216/135302
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/135302

Internet

https://hdl.handle.net/10216/135302

Similar Items